Showing results (131-140 of 143) with videos related to
Sort By:
Pageof 15
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1981
Xenon NMR: chemical shifts of a general anesthetic in common solvents, proteins, and membranesK W Miller, N V Reo, A J Schoot Uiterkamp, et al.Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|November 5, 1997
Comparison of olestra absorption in guinea pigs with normal and compromised gastrointestinal tractsG C Daher, K D Lawson, P H Long, et al.Biochemistry|November 14, 2001
Conformational changes in pediocin AcH upon vesicle binding and approximation of the membrane-bound structure in detergent micellesR M Watson, R W Woody, R V Lewis, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 1992
Conditions affecting the immunohistochemical detection of HIV in fixed and embedded renal and nonrenal tissuesT Nadasdy, O Hanson-Painton, L D Davis, et al.Clinical Pharmacology and Therapeutics|April 1, 1980
Effect of cardiopulmonary bypass on cefazolin dispositionK W Miller, H G McCoy, K K Chan, et al.The American Journal of Clinical Nutrition|May 1, 1991
Serum 25-hydroxyvitamin D concentrations of free-living subjects consuming olestraD Y Jones, K W Miller, B P Koonsvitsky, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 1, 1992
Is cytomegalovirus associated with renal disease in AIDS patients?T Nadasdy, K W Miller, L D Johnson, et al.Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|February 1, 1995
Disposition of ingested olestra in the Fischer 344 ratK W Miller, K D Lawson, D H Tallmadge, et al.Journal of Medicinal Chemistry|August 28, 1999
Synthesis and properties of 3-(2-hydroxyethyl)-3-n-pentyldiazirine, a photoactivable general anestheticS S Husain, S A Forman, M A Kloczewiak, et al.Reviews on Recent Clinical Trials|December 25, 2012
Skin benefits with a novel emollient-treated menstrual padM A Farage, K W Miller, C E Azuka, et al.Pageof 15